Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil

• Autor(a) principal: Giacomazzi, Juliana
• Data de Publicação: 2014
• Outros Autores: Graudenz, Márcia Silveira, Osório, Cynthia Aparecida Bueno de Toledo, Santos, Patrícia Koehler dos, Palmero, Edenir Inêz, Oliveira, Marcelo Zagonel de, Michelli, Rodrigo Augusto Depieri, Scapulatempo Neto, Cristovam, Fernandes, Gabriela de Carvalho, Achatz, Maria Isabel Alves de Souza Waddington, Martel-Planche, Ghyslaine, Soares, Fernando A., Caleffi, Maira, Goldim, José Roberto, Hainaut, Pierre, Camey, Suzi Alves, Prolla, Patrícia Ashton
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFRGS
• Texto Completo: http://hdl.handle.net/10183/194038
• topic: Genes p53; Neoplasias da mama; Mutação

Germline TP53 mutations predispose individuals to multiple cancers and are associated with Li-Fraumeni/Li-Fraumeni-Like Syndromes (LFS/LFL). The founder mutation TP53 p.R337H is detected in 0.3% of the general population in southern Brazil. This mutation is associated with an increased risk of childhood adrenal cortical carcinoma (ACC) but is also common in Brazilian LFS/LFL families. Breast Cancer (BC) is one of the most common cancers diagnosed in TP53 mutation carriers. We have assessed the prevalence of p.R337H in two groups: (1) 59 BC affected women with a familial history (FH) suggestive of hereditary cancer syndrome but no LFS/LFL features; (2) 815 BC affected women unselected for cancer FH, diagnosed with BC at or before age 45 or at age 55 or older. Among group 1 and group 2 patients, 2/59 (3.4%, CI95%: 0.4%–11.7%) and 70/ 815 (8.6%, CI95%: 6.8%–10.7%), respectively, were p.R337H carriers in the germline. The prevalence of p.R337H was higher in women diagnosed with BC at or before age 45 (12.1%, CI95%: 9.1%–15.8%) than at age 55 or older (5.1%, CI95%: 3.2%– 7.7%), p,0.001). The Brazilian founder p.R337H haplotype was detected in all carriers analysed. These results suggest that inheritance of p.R337H may significantly contribute to the high incidence of BC in Brazil, in addition to its recently demonstrated impact on the risk of childhood ACC.